NewsBenzingaUBS mantiene su recomendación neutral sobre Revolve Group y reduce el precio objetivo a 26 dólares. UBS mantiene su recomendación neutral sobre Revolve Group y reduce el precio objetivo a 26 dólares. Benzinga 2026.11.04 23:20 (GMT+0) Open on Benzinga Other news Avalo Therapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed Wells Fargo CIB CEO Fernando Rivas Says Our Corporate Investment Banking Pipelines Are At An All-Time High Lipocine Q3 EPS $(0.08) Beats $(0.32) Estimate, Sales $2.290M Beat $159.500K Estimate McDonald's To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Thursday Susquehanna Maintains Positive on GATX, Raises Price Target to $220 SCYNEXIS Q3 EPS $(0.71) Beats $(0.72) Estimate
Wells Fargo CIB CEO Fernando Rivas Says Our Corporate Investment Banking Pipelines Are At An All-Time High
